Leopold von Balthazar

Projekte

• Forschung und Entwicklung Zellphysiologie / Teammitglied / abgeschlossen
• A platform enabling efficient and effective delivery and packaging of therapeutic molecules / Teammitglied / abgeschlossen
• Novel cell-based immunization technology and functional validation of resulting antibodies / Teammitglied / abgeschlossen

Publikationen

Beiträge in wissenschaftlicher Zeitschrift, peer-reviewed

• Beffinger, M., Schellhammer, L., Taşkoparan, B., Deplazes, S., Salazar, U., Tatari, N., Seehusen, F., von Balthazar, L., Zinner, C., Spath, S., Shekarian, T., Ritz, M.-F., McDaid, M., Egloff, P., Zimmermann, I., Okada, H., Ward, E. S., Rohrer, J., Seeger, M. A., et al. (2025). FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma. Nature Communications, 2025(16), 4751. https://doi.org/10.1038/s41467-025-59971-0
• Eggenschwiler, J., von Balthazar, L., Stritt, B., Pruntsch, D., Ramos, M., Urech, K., Rist, L., Simões-Wüst, A. P., & Viviani, A. (2007). Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata). BMC Complementary and Alternative Medicine, 7(14). https://doi.org/10.1186/1472-6882-7-14

Weitere Publikationen

Wagschal, I., Eggenschwiler, J., von Balthazar, L., Patrignani, A., Rehrauer, H., Schlapbach, R., Ramos, M. H., & Viviani, A. (2007). Gene expression signatures of pathways alterations in tumor cells caused by plant extracts [Conference paper]. Medicina, 67(Suppl. II), 97–106. https://doi.org/10.21256/zhaw-2770

Zurück